Patents by Inventor Ierachimiel Daskal

Ierachimiel Daskal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6790622
    Abstract: This invention provides a novel nucleic acid molecule encoding PTX1, which has been mapped to human chromosome 12. The PTX1-encoding nucleic acid molecule, along with its encoded protein and antibodies thereto may be used to advantage to facilitate the diagnosis, prognosis and treatment of cancer.
    Type: Grant
    Filed: March 8, 2002
    Date of Patent: September 14, 2004
    Assignee: Albert Einstein Healthcare Network
    Inventors: Simon Kwok, Ierachimiel Daskal
  • Patent number: 6743603
    Abstract: This invention provides a novel nucleic acid molecule encoding PTX1, which has been mapped to human chromosome 12. The PTX1-encoding nucleic acid molecule, along with its encoded protein and antibodies thereto may be used to advantage to facilitate the diagnosis, prognosis and treatment of cancer.
    Type: Grant
    Filed: August 22, 2001
    Date of Patent: June 1, 2004
    Assignee: Albert Einstein Healthcare Network
    Inventors: Simon Kwok, Ierachimiel Daskal
  • Publication number: 20020132262
    Abstract: This invention provides a novel nucleic acid molecule encoding PTX1, which has been mapped to human chromosome 12. The PTX1-encoding nucleic acid molecule, along with its encoded protein and antibodies thereto may be used to advantage to facilitate the diagnosis, prognosis and treatment of cancer.
    Type: Application
    Filed: March 8, 2002
    Publication date: September 19, 2002
    Inventors: Simon Kwok, Ierachimiel Daskal
  • Publication number: 20020045217
    Abstract: This invention provides a novel nucleic acid molecule encoding PTX1, which has been mapped to human chromosome 12. The PTX1-encoding nucleic acid molecule, along with its encoded protein and antibodies thereto may be used to advantage to facilitate the diagnosis, prognosis and treatment of cancer.
    Type: Application
    Filed: August 22, 2001
    Publication date: April 18, 2002
    Inventors: Simon Kwok, Ierachimiel Daskal